Search Results - "Provan, S."

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis by Peters, M J L, Symmons, D P M, McCarey, D, Dijkmans, B A C, Nicola, P, Kvien, T K, McInnes, I B, Haentzschel, H, Gonzalez-Gay, M A, Provan, S, Semb, A, Sidiropoulos, P, Kitas, G, Smulders, Y M, Soubrier, M, Szekanecz, Z, Sattar, N, Nurmohamed, M T

“…To develop evidence-based EULAR recommendations for cardiovascular (CV) risk management in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS)…”
Get more information

Less-structured time in children's daily lives predicts self-directed executive functioning by Barker, Jane E, Semenov, Andrei D, Michaelson, Laura, Provan, Lindsay S, Snyder, Hannah R, Munakata, Yuko

“…Executive functions (EFs) in childhood predict important life outcomes. Thus, there is great interest in attempts to improve EFs early in life. Many…”
Get full text

A validation of register-derived diagnoses of interstitial lung disease in patients with inflammatory arthritis: data from the NOR-DMARD study by Provan, S A, Ahlfors, F, Bakland, G, Hu, Y, Kristianslund, E K, Ikdahl, E, Kvien, T K, Aaløkken, T M, Hoffmann-Vold, A M

“…There is a lack of knowledge concerning the validity of the interstitial lung disease (ILD) diagnoses used in epidemiological studies on rheumatic diseases…”
Get full text

SARS-CoV-2 Positivity in Asymptomatic-Screened Dental Patients by Conway, D.I., Culshaw, S., Edwards, M., Clark, C., Watling, C., Robertson, C., Braid, R., O’Keefe, E., McGoldrick, N., Burns, J., Provan, S., VanSteenhouse, H., Hay, J., Gunson, R.

“…Enhanced community surveillance is a key pillar of the public health response to coronavirus disease 2019 (COVID-19). Asymptomatic carriage of severe acute…”
Get full text

High-intensity cardiorespiratory and strength exercises reduced emotional distress and fatigue in patients with axial spondyloarthritis: a randomized controlled pilot study by Sveaas, SH, Berg, IJ, Fongen, C, Provan, SA, Dagfinrud, H

“…Objective: To investigate the effect of high-intensity exercise on emotional distress, fatigue, and ability to do a full day's activities in patients with…”
Get full text

The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries by Di Giuseppe, Daniela, Lindström, Ulf, Aaltonen, Kalle, Relas, Heikki, Provan, Sella, Gudbjornsson, Bjorn, Hetland, Merete Lund, Askling, Johan, Kauppi, Markku, Geirsson, Arni Jon, Chatzidionysiou, Katerina, Jørgensen, Tanja Schjødt, Dreyer, Lene, Michelsen, Brigitte, Jacobsson, Lennart, Glintborg, Bente

“…In axial spondyloarthritis (axSpA), switching between multiple biologic or targeted synthetic (b/ts-) DMARDs might indicate difficult-to-treat disease. We…”
Get full text

Circulating levels of inflammatory cytokines and cytokine receptors in patients with ankylosing spondylitis: a cross-sectional comparative study by Sveaas, SH, Berg, IJ, Provan, SA, Semb, AG, Olsen, IC, Ueland, T, Aukrust, P, Vøllestad, N, Hagen, KB, Kvien, TK, Dagfinrud, H

“…Objectives: Insight into the most important inflammatory pathways in ankylosing spondylitis (AS) could be of importance in risk stratification and the…”
Get full text

Biological treatment in ankylosing spondylitis in the Nordic countries during 2010-2016: a collaboration between five biological registries by Glintborg, B, Lindström, U, Aaltonen, K, Kristianslund, EK, Gudbjornsson, B, Chatzidionysiou, K, Askling, J, Nordström, D, Hetland, ML, Di Giuseppe, D, Dreyer, L, Kristensen, LE, Jørgensen, TS, Eklund, K, Grondal, G, Ernestam, S, Joensuu, J, Törmänen, MRK, Skydsgaard, H, Hagfors, J, Kvien, TK, Lie, E, Fagerli, K, Geirsson, AJ, Jonsson, H, Provan, SA, Krogh, NS, Jacobsson, LTH

“…Objectives: Large-scale observational cohorts may be used to study the effectiveness and rare side effects of biological disease-modifying anti-rheumatic drugs…”
Get full text

Biomarkers of cardiovascular risk across phenotypes of osteoarthritis by Provan, S A, Rollefstad, S, Ikdahl, E, Mathiessen, A, Berg, I J, Eeg, I, Wilkinson, I B, McEniery, C M, Kvien, T K, Hammer, H B, Østerås, N, Haugen, I K, Semb, A G

“…The objective of this study was to explore the associations between ultrasonographic and radiographic joint scores and levels of arterial CVD risk markers in…”
Get full text

Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries by Glintborg, Bente, Di Giuseppe, Daniela, Wallman, Johan Karlsson, Nordström, Dan C, Gudbjornsson, Bjorn, Hetland, Merete Lund, Askling, Johan, Grondal, Gerdur, Sokka, Tuulikki, Provan, Sella A, Michelsen, Brigitte, Kristianslund, Eirik Klami, Dreyer, Lene, Love, Thorvardur Jon, Lindström, Ulf

“…We aimed to describe the uptake of newer biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in psoriatic arthritis (PsA) in the…”
Get more information

Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries by Glintborg, Bente, Di Giuseppe, Daniela, Wallman, Johan K, Provan, Sella A, Nordström, Dan, Hokkanen, Anna-Mari, Österlund, Jenny, Kristianslund, Eirik, Kvien, Tore K, Gudbjornsson, Bjorn, Hetland, Merete Lund, Michelsen, Brigitte, Jacobsson, Lennart, Askling, Johan, Lindström, Ulf

“…The positioning of secukinumab in the treatment of axial SpA (axSpA) and PsA is debated, partly due to a limited understanding of the comparative safety of the…”
Get full text

Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis by Lindström, Ulf, Glintborg, Bente, Di Giuseppe, Daniela, Schjødt Jørgensen, Tanja, Gudbjornsson, Bjorn, Lederballe Grøn, Kathrine, Aarrestad Provan, Sella, Michelsen, Brigitte, Lund Hetland, Merete, Wallman, Johan K, Nordström, Dan, Trokovic, Nina, Love, Thorvardur Jon, Krogh, Niels Steen, Askling, Johan, Jacobsson, Lennart T H, Kristensen, Lars Erik

“…To compare treatment retention and response to secukinumab vs adalimumab, including the other four TNF inhibitors (TNFi) as comparators, in PsA. All patients…”
Get full text

Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study by Provan, Sella A, Semb, Anne Grete, Hisdal, Jonny, Stranden, Einar, Agewall, Stefan, Dagfinrud, Hanne, Angel, Kristin, Atar, Dan, Kvien, Tore K

“…To compare markers of cardiovascular disease (CVD) risk between patients with rheumatoid arthritis (RA) in an active disease state and those with RA in…”
Get more information

Effectiveness of a second biologic after failure of a non-tumor necrosis factor inhibitor as first biologic in rheumatoid arthritis by Chatzidionysiou, Katerina, Hetland, Merete Lund, Frisell, Thomas, Di Giuseppe, Daniela, Hellgren, Karin, Glintborg, Bente, Nordström, Dan, Peltomaa, Ritva, Aaltonen, Kalle, Trokovic, Nina, Kristianslund, Eirik K, Kvien, Tore K, Provan, Sella A, Gudbjornsson, Bjorn, Grondal, Gerdur, Dreyer, Lene, Kristensen, Lars Erik, Jørgensen, Tanja Schjødt, Jacobsson, Lennart T H, Askling, Johan

“…In Rheumatoid Arthritis (RA), evidence regarding the effectiveness of a second biologic Disease Modifying Anti-Rheumatic Drugs (bDMARDs) in patients whose…”
Get full text

Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study by Lund Hansen, Rebekka, Schoedt Jørgensen, Tanja, Dreyer, Lene, Hetland, Merete L, Glintborg, Bente, Askling, Johan, Di Giuseppe, Daniela, Jacobsson, Lennart T H, Wallman, Johan K, Nordstrom, Dan, Aaltonen, Kalle, Kristianslund, Eirik K, Kvien, Tore K, Provan, Sella A, Gudbjornsson, Bjorn, Love, Thorvadur J, Kristensen, L E

“…Abstract Objectives To assess secular trends in baseline characteristics of PsA patients initiating their first or subsequent biologic DMARD (bDMARD) therapy…”
Get full text

Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritis by Lindström, Ulf, Glintborg, Bente, Di Giuseppe, Daniela, Nordström, Dan, Aarrestad Provan, Sella, Gudbjornsson, Bjorn, Askling, Johan, Lund Hetland, Merete, Aaltonen, Kalle, Krogh, Niels Steen, Geirsson, Arni Jon, Jacobsson, Lennart T H

“…ObjectiveAlthough clinical trials support equivalence of originator products and biosimilars for etanercept and infliximab, real-world studies among…”
Get full text

P4.02: Baseline Crp But Not Nsaid-Use Predicts Future Increased Arterial Stiffness in Ankylosing Spondylitis: Results after 5-Year Follow Up by Berg, I. J., Semb, A. G., van der Heijde, D., Kvien, T. K., Dagfinrud, H., Provan, S. A.

“…Objective Patients with ankylosing spondylitis (AS) have an increased risk of CVD, but previous studies have not shown a worsened risk profile regarding…”
Get full text

P5.14: High Intensity Aerobic Exercise in Patients with Ankylosing Spondylitis Reduces Arterial Stiffness: Results From a Randomized Controlled Trial by Berg, I. J., Semb, A. G., Halvorsen, S., Fongen, C., Kvien, T. K., Dagfinrud, H., Provan, S. A.

“…Objective Patients with ankylosing spondylitis (AS) are at increased risk of CVD. The etiological mechanism or how to reduce risk is not known. Exercise can…”
Get full text

Examination of effects of Tnf-alpha antagonists on arterial stiffness in patients with rheumatoid arthritis and related arthropathies: a controlled study by Angel, K, Provan, S, Kvien, T.K, Atar, D

Get full text

04.02 Examination of Effects of TNF-Alpha Antagonists on Arterial Stiffness in Patients with Rheumatoid Arthritis and Related Arthropathies: A Controlled Study by Angel, K., Provan, S., Kvien, T. K., Atar, D.

“…Objective It has been suggested that the chronic inflammatory state of rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA)…”
Get full text